Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET

Company Participants

Fred Lampropoulos - Founder, Chairman & Chief Executive Officer
Brian Lloyd - Chief Legal Officer & Corporate Secretary
Joe Wright - President
Raul Parra - Chief Financial Officer

Conference Call Participants

John Young - Canaccord
Jayson Bedford - Raymond James
Jason Bednar - Piper Sandler
David Rescott - R.W. Baird
Mike Matson - Needham
Craig Bijou - Bank of America Securities
Jim Sidoti - Sidoti & Company
Michael Petusky - Barrington Research
Steve Lichtman - Oppenheimer

Operator

Good day, and thank you for standing by. Welcome to the Merit Medical Q3 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to turn the conference over to your speaker for today, Fred Lampropoulos. Please go ahead.

Fred Lampropoulos

Thank you, operator, and welcome, everyone. I am joined on the call today by Raul Parra, our Chief Financial Officer and Treasurer; Joe Wright, our President; and Brian Lloyd, our Chief Legal Officer and Corporate Secretary.

I am joined on the call today by Raul Parra, our Chief Financial Officer and Treasurer; Joe Wright, our President; and Brian Lloyd, our Chief Legal Officer and Corporate Secretary.

Brian, would you mind taking us through the safe harbor statements, please?

Brian Lloyd

Thank you, Fred. I would like to remind everyone that this presentation contains forward-looking statements that receive safe harbor protection under federal securities laws. Although, we believe these forward-looking statements are based upon reasonable assumptions, they are subject to risks and uncertainties. The realization of any of these risks or uncertainties, as well as extraordinary events or transactions impacting our company could cause actual results to differ materially from the expectations and projections expressed or implied by our forward-looking statements.

In addition, any forward-looking statements represent our views only as of today, October 30, 2024, and should not be relied upon, as representing our views as of any other date. We specifically disclaim any obligation to update such statements, except as required by applicable law.

Please refer to the section entitled Cautionary Statement regarding Forward-Looking Statements in today's press release and presentation for important information regarding such statements. For a discussion of factors, which could cause actual results to differ from these forward-looking statements, please also refer to our most recent filings with the SEC, which are available on our website.